I’ve been reflecting on how my experiences as an angel investor have unexpectedly refined my skills in the IVF consultation room. At first glance, these two worlds might seem worlds apart, but they share a common thread—listening. I’ve learned that the art of listening is as crucial when guiding a startup founder as it is when counseling a hopeful couple in my clinic.
I recall a particularly busy week at the clinic. We had a couple in their late thirties who had been trying to conceive for over two years. As they sat in my consultation room, I could sense their anxiety. They were well-read, had done their research, and came armed with a list of questions. I realized that what they needed most at that moment was not just medical expertise, but an empathetic ear. They needed someone who could listen, understand their journey, and provide reassurance amidst the chaos of medical jargon and procedures.
This experience was reminiscent of a meeting I had with a young founder a few weeks earlier. He had a brilliant idea but was overwhelmed by the myriad challenges of launching a startup. He came to me not just for investment but for guidance. The parallels were striking. In both cases, listening was paramount. It wasn’t just about hearing their words but understanding their fears, aspirations, and motivations.
Listening is often underestimated in both the startup and medical worlds. In investing, there’s a temptation to dominate the conversation with advice and opinions—after all, we’re putting our money on the line. Similarly, in the medical field, the pressure to present solutions can overshadow the patient’s narrative. But what I’ve learned is that true listening can lead to better outcomes in both arenas.
In IVF, every patient’s journey is unique. Their emotional landscape is as varied as their medical history. And while the science is critical, the human element is what makes a difference. This is where listening plays a transformative role. It’s about piecing together the unspoken cues, the hesitations, and the hopes that the patient may not articulate directly.
When I listen to a founder, I do so with the awareness that I’m not just investing in an idea but in the person behind it. This perspective has shaped how I approach patient consultations. Just as a startup requires nurturing and patience, so does a patient’s reproductive journey. Both paths are fraught with uncertainties, and listening is the compass that guides them.
One instance that stands out involved a patient who had undergone multiple failed IVF cycles. She was understandably frustrated and on the brink of giving up. Instead of immediately suggesting another round of treatment, I listened. I discovered her fears went beyond the medical—they were deeply personal and emotional. She needed to be heard and to process her experiences before deciding on the next step. This approach, influenced by my experience with startups, allowed her to regain confidence and ultimately choose a path that was right for her.
In investing, I’ve learned to appreciate the power of pause. Allowing a founder to express their vision without interruption often reveals insights that might otherwise be overlooked. This same patience applies in the consultation room. Giving patients the space to share their story not only builds trust but often uncovers critical information that can shape their treatment plan.
Moreover, the feedback loop is invaluable. Whether it’s a startup iterating on a product or a patient updating me on their treatment progress, actively seeking and valuing their input creates a partnership. In IVF, this means regularly checking in with patients, understanding their evolving needs, and adapting the approach as necessary. It’s a dynamic process, much like the iterative nature of startups.
I’ve also realized that the art of listening is not just about the here and now. It’s about fostering long-term relationships. In the startup world, a successful investment is one where the founder feels supported throughout their journey. Similarly, in IVF, the goal is to support patients not just through their current cycle but through their entire reproductive journey, regardless of the outcome.
This approach has led me to embrace transparency and honesty, even when the truth is difficult. Just as I would advise a founder to pivot if their current strategy isn’t working, I owe it to my patients to be candid about their prognosis and options. This honesty builds trust, which is the foundation of any successful relationship, be it with a startup or a patient.
Reflecting on these experiences, I’ve come to appreciate the symbiotic relationship between investing and medicine. Each has enriched the other in unexpected ways. Listening, I’ve found, is a skill that transcends disciplines. It is as vital in diagnosing a patient’s needs as it is in evaluating a startup’s potential.
In conclusion, the lessons I’ve learned from investing have profoundly influenced how I approach patient care in IVF. Listening, truly listening, is a skill that can transform outcomes in both fields. As I continue to navigate these worlds, I remain committed to honing this skill, knowing that it is the key to understanding and serving those who place their trust in me.